Epizyme, Inc. to Present at 34th Annual Cowen and Company Health Care Conference on March 3, 2014

[PR Newswire] – CAMBRIDGE, Mass., Feb. 28, 2014 /PRNewswire/ — Epizyme, Inc. (EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, today announced its participatio more

View todays social media effects on EPZM

View the latest stocks trending across Twitter. Click to view dashboard

See who Epizyme is hiring next, click here to view